Summary & Overview
CPT 16034: Dermatologic Procedural Service
CPT code 16034 denotes a specific procedural service captured in the Current Procedural Terminology (CPT) system. As a recognized CPT surgical/procedural code, it has relevance for billing, coding accuracy, and payment across outpatient and ambulatory surgical settings nationwide. Correct identification of CPT code 16034 supports consistent claims submission and insurer adjudication.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a national perspective on how CPT code 16034 is categorized and used across payers, highlighting billing context, typical sites of service, and implications for facility and professional billing workflows.
Readers will find an overview of the clinical context tied to the code, discussion of typical sites of service, payer coverage considerations, and national benchmarking context where available. The report also outlines what information is not available in the input, such as specific modifiers, associated taxonomies, ICD-10 diagnoses, and related codes, so readers understand limits of the current summary.
Billing Code Overview
CPT code 16034 represents a procedure described as 16034. The service is a surgical or procedural intervention as indicated by the CPT numeric code and is typically performed in an outpatient surgical setting or ambulatory care facility.
Service Type: Data not available in the input.
Typical Site of Service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient dermatology clinic with one or more cutaneous benign or premalignant lesions (such as actinic keratoses, seborrheic keratoses, or small benign nevi) for which chemical or mechanical debridement with an application of an enzyme preparation is indicated. The workflow begins with history and focused skin examination, informed consent for topical enzymatic debridement, documentation of lesion location, size, and number, and photographic or diagrammatic recording when required. The procedure is performed in a procedure room or office dermatology suite: the area is cleaned, the enzyme agent is applied to the lesion(s) per manufacturer instructions, allowed to remain for the specified duration, and then removed; post-procedure wound care instructions are provided. Typical follow-up occurs in 1–4 weeks to assess response and healing, and additional treatments may be scheduled if necessary. The typical site of service is an outpatient clinic or dermatology office procedure room. The service type is dermatologic topical enzymatic wound or lesion debridement/chemical destruction consistent with billing code 16034.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M visit is documented on the same day as that goes beyond usual pre- and post-procedure work |